Drug Reclassification: An Analysis of Organizational and Professional Perspectives.
AIR FORCE INST OF TECH WRIGHT-PATTERSON AFB OHIO
Pagination or Media Count:
The concept of establishing a non-prescription intermediate class of drugs, available only from pharmacists, was analyzed to determine the primary obstacles to its gaining acceptance. Its sanction by the legislative system would serve to officially recognize the pharmacists role in applied clinical therapeutics. The conclusions and implications of the authors findings for the future of this concept and the future of legislative recognition for the clinical therapeutic role of pharmacists are not favorable. The proprietary drug industrys opposition to the reclassification concept has been transformed into opposition to the expanded role functions of pharmacists. This presents a serious threat to professional role revitalization for pharmacists. The author recommends that pharmacists resolve their differences of opinion on professional role functions, establish a restricted class from OTC drugs now available to them to demonstrate their concern and ability, and begin to solicit outside support for their positions.